Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
Here's a roundup of top developments in the biotech space over the last 24 hours:
This Analyst Expects Stabilization Across Canadian Cannabis Market, Revises Sales Estimates For Cannabis LPs
The Canadian cannabis industry has become a competitive field over the past few years, which doesn’t come as a surprise considering its exponential growth over the same period.
Tabula Rasa Sees Better Than Expected Q2 Sales, Just As Investor Calls For Removal Of Top Executives
Tabula Rasa HealthCare Inc (NASDAQ:TRHC) expects Q2 sales of $72 – $73 million, exceeding the prior guidance range of $66…
X4 Pharma To Stop Further Work On Oncology Programs, Looks For Partner(s)
X4 Pharmaceuticals Inc (NASDAQ:XFOR) updated its strategic priorities that include streamlining resources to focus on advancing its lead candidate, mavorixafor, in…
WEED Inc. Acquires Hempirical Genetics, With Over 250 Proprietary Cannabis & Hemp Strains For $750K
WEED, Inc. (OTCQB: BUDZ) a global cannabis & hemp bioresearch company based in the USA, focused on the development and application of cannabis-derived compounds for the treatment of human and animal diseases, acquired 100% of Hempirical Genetics, LLC, for 2 million shares
Disappointing Data Forces Assembly Bio Stop Combo Trial For HBV Infection
Assembly Biosciences Inc (NASDAQ:ASMB) will stop working on its first-generation core inhibitor, vebicorvir (VBR), as it prioritizes its next-gen core…
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
Gainers
Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
DiDi Fined $1.2B In China: Is The Company Finally Out Of Rough Waters?
China has fined ride-hailing app DiDi Global Inc – ADR (OTC: DIDIY) $1.2 billion for violating its data security law, cyber security law and personal information protection law. The decision has brought to conclusion a year-long investigation into the firm.